chr18-74353975-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001174123.2(C18orf63):c.1708G>C(p.Glu570Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000547 in 1,536,126 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001174123.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
C18orf63 | NM_001174123.2 | c.1708G>C | p.Glu570Gln | missense_variant | 12/14 | ENST00000579455.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
C18orf63 | ENST00000579455.2 | c.1708G>C | p.Glu570Gln | missense_variant | 12/14 | 1 | NM_001174123.2 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.0000329 AC: 5AN: 152106Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000869 AC: 12AN: 138064Hom.: 0 AF XY: 0.0000669 AC XY: 5AN XY: 74684
GnomAD4 exome AF: 0.0000571 AC: 79AN: 1384020Hom.: 0 Cov.: 35 AF XY: 0.0000542 AC XY: 37AN XY: 682942
GnomAD4 genome ? AF: 0.0000329 AC: 5AN: 152106Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74308
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 18, 2021 | The c.1708G>C (p.E570Q) alteration is located in exon 12 (coding exon 11) of the C18orf63 gene. This alteration results from a G to C substitution at nucleotide position 1708, causing the glutamic acid (E) at amino acid position 570 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at